| Anticancer activity of curcumin and its analogues: preclinical and clinical studies A Allegra, V Innao, S Russo, D Gerace, A Alonci, C Musolino Cancer investigation 35 (1), 1-22, 2017 | 216 | 2017 |
| Inflammatory and anti-inflammatory equilibrium, proliferative and antiproliferative balance: the role of cytokines in multiple myeloma C Musolino, A Allegra, V Innao, AG Allegra, G Pioggia, S Gangemi Mediators of inflammation 2017, 2017 | 141 | 2017 |
| The cancer stem cell hypothesis: a guide to potential molecular targets A Allegra, A Alonci, G Penna, V Innao, D Gerace, F Rotondo, C Musolino Cancer Investigation 32 (9), 470-495, 2014 | 104 | 2014 |
| Immunoproteasome-selective and non-selective inhibitors: A promising approach for the treatment of multiple myeloma R Ettari, M Zappalà, S Grasso, C Musolino, V Innao, A Allegra Pharmacology & Therapeutics 182, 176-192, 2018 | 99 | 2018 |
| New orally active proteasome inhibitors in multiple myeloma A Allegra, A Alonci, D Gerace, S Russo, V Innao, L Calabrò, C Musolino Leukemia research 38 (1), 1-9, 2014 | 97 | 2014 |
| Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies A Allegra, V Innao, AG Allegra, C Musolino Annals of hematology 99 (9), 1953-1965, 2020 | 84 | 2020 |
| Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma A Allegra, G Penna, A Alonci, S Russo, B Greve, V Innao, V Minardi, ... European journal of haematology 90 (6), 441-468, 2013 | 61 | 2013 |
| Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw C Musolino, G Oteri, A Allegra, M Mania, A D’Ascola, A Avenoso, V Innao, ... Annals of hematology 97, 1259-1269, 2018 | 52 | 2018 |
| Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease. C Musolino, A Allegra, M Profita, A Alonci, S Saitta, S Russo, A Bonanno, ... British journal of haematology 160 (5), 2013 | 51 | 2013 |
| Adoptive immunotherapy for hematological malignancies: Current status and new insights in chimeric antigen receptor T cells A Allegra, V Innao, D Gerace, D Vaddinelli, C Musolino Blood Cells, Molecules, and Diseases 62, 49-63, 2016 | 46 | 2016 |
| Nanobodies and cancer: current status and new perspectives A Allegra, V Innao, D Gerace, D Vaddinelli, AG Allegra, C Musolino Cancer investigation 36 (4), 221-237, 2018 | 41 | 2018 |
| Formaldehyde exposure and acute myeloid leukemia: a review of the literature A Allegra, G Spatari, S Mattioli, S Curti, V Innao, R Ettari, AG Allegra, ... Medicina 55 (10), 638, 2019 | 36 | 2019 |
| The metabolomic signature of hematologic malignancies A Allegra, V Innao, D Gerace, O Bianco, C Musolino Leukemia Research 49, 22-35, 2016 | 34 | 2016 |
| Reduced dose-intensity subcutaneous bortezomib plus prednisone (VP) or plus cyclophosfamide (VCP) or plus melphalan (VMP) for newly diagnosed multiple myeloma patients older … A Larocca, F Cavallo, V Magarotto, M Offidani, V Federico, V Innao, ... Blood 122 (21), 539, 2013 | 31 | 2013 |
| Lymphocyte subsets and inflammatory cytokines of monoclonal gammopathy of undetermined significance and multiple myeloma A Allegra, V Innao, AG Allegra, M Pugliese, E Di Salvo, ... International Journal of Molecular Sciences 20 (11), 2822, 2019 | 29 | 2019 |
| Antiresorptive agents and anti-angiogenesis drugs in the development of osteonecrosis of the jaw A Allegra, V Innao, N Pulvirenti, C Musolino The Tohoku Journal of Experimental Medicine 248 (1), 27-29, 2019 | 28 | 2019 |
| Telomerase and telomere biology in hematological diseases: A new therapeutic target A Allegra, V Innao, G Penna, D Gerace, AG Allegra, C Musolino Leukemia Research 56, 60-74, 2017 | 26 | 2017 |
| Vaccination of multiple myeloma: Current strategies and future prospects A Allegra, G Penna, V Innao, B Greve, V Maisano, S Russo, C Musolino Critical Reviews in Oncology/Hematology 96 (2), 339-354, 2015 | 26 | 2015 |
| Therapeutic potential of antagomiRs in haematological and oncological neoplasms V Innao, A Allegra, N Pulvirenti, AG Allegra, C Musolino European Journal of Cancer Care 29 (2), e13208, 2020 | 25 | 2020 |
| Role of the microbiota in hematologic malignancies A Allegra, V Innao, AG Allegra, R Ettari, M Pugliese, N Pulvirenti, ... Neth. J. Med 77 (2), 67-80, 2019 | 24 | 2019 |
